Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial.

Youyi FongYing HuangBhavesh BorateLars W P van der LaanWenbo ZhangLindsay N CarppIksung ChoGreg GlennLouis FriesRaphael GottardoPeter B Gilbert

Published in: Open forum infectious diseases (2023)

Our results suggest that the vaccine induced protective anti-F antibody responses. If this finding is confirmed, VE could potentially be augmented by increasing these responses.

Keyphrases

respiratory syncytial virus
drug induced
study protocol
diabetic rats
clinical trial
early onset
randomized controlled trial
open label